Pharmacoscintigraphic evaluation of polysorbate80-coated chitosan nanoparticles for brain targeting

American Journal of Drug Delivery

Volumn 3, Issue 3, 2005, Pages 205-212

  Soni, Sheetal ^a   Babbar, Anil Kumar ^a   Sharma, Rakesh Kumar ^a   Banerjee, Tanima ^b   Maitra, Amarnath ^b  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; CHITOSAN TC 99M; DRUG CARRIER; GLUTARALDEHYDE; NANOPARTICLE; POLYSORBATE 80; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN; BRAIN SCINTISCANNING; BRAIN TISSUE; CONTROLLED STUDY; CROSS LINKING; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG COATING; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG UPTAKE; FEMALE; HYDROPHOBICITY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; REVERSE MICELLE; TARGET ORGAN;

EID: 31144479662     PISSN: 11759038     EISSN: 11759038     Source Type: Journal    
DOI: 10.2165/00137696-200503030-00004     Document Type: Article

References (29)

1. Grelg NH. Drug delivery to the brain by blood-brain barrier circumvention and drug modification. In: Neuwelt EA, editor. Implications of the blood-brain barrier and its manipulation. New York: Plenum Press, 1994: 311-57
2. Neuwelt EA, Barnett PA, Hellstrom KE, et al. Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts. J Nucl Med 1994; 35: 1831-41
3. Waltre KA, Tamargo RJ, Olivi A, et al. Intratumoral chemotherapy. Neurosurg 1995 Dec; 37 (6): 1128-45
4. Kavanov AV, Batrakova EV. New technologies for drug delivery across the blood brain barrier: a review. Curr Pharm Des 2004; 10 (12): 1355-63
5. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001; 47: 65-81
6. Muller RH, Keck CM. Drug delivery to the brain: realization by novel drug carriers. J Nanosci Nanotechnol 2004 May; 4 (5): 471-83
7. Moghimi SM, Hunter AC, Murray JC. Long circulating and target specific nanoparticles: theory to review. Pharmacol Rev 2001 Jun; 53 (2): 283-318
8. Couvreur P, Dubernet C, Fuisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm 1995; 41: 2-13
9. Alyaudtin RN, Reichel A, Lobenberg R, et al. Interaction of poly(butylcyanoacrylate) with the blood brain barrier in vivo and in vitro. J Drug Target 2001 Jun; 9 (3): 209-21
10. Kreuter J. Evaluation of nanoparticles as drug delivery systems 11: comparison of body distribution of microspheres (diameter > 1 μm), liposomes and emulsions. Pharm Acta Helv 1983; 58: 217-26
11. Torchlin VP. Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 1998 Jan-Feb; 5 (1): 1-19
12. Alyautdin RN, Kreuter J, Kharkevich DA, et al. Drug delivery to the brain with nanoparticles [in Russian]. Eksp Klin Farmakol 2003 Mar-Apr; 66 (2): 65-8
13. Borchard G, Audus KL, Shi F, et al. Uptake of surfactant coated poly(methylmethacrylate) nanoparticles by bovine brain endothelial cell mono-layers. Int J Pharm 1994; 10: 29-35
14. Kreuter J, Petrov VE, Kharkevich DA, et al. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant coated nanoparticles. J Control Release 1997; 49: 81-7
15. Alyautdin RN, Tezikov EB, Ramge P, et al. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate80 coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J Microencapsul 1998; 15: 67-74
16. Alyautdin RA, Petrov VE, Langer K, et al. Delivery of loperamide across the blood-brain barrier with polysorbate80 coated poly(butylcyanoacrylate) nanoparticles. Pharm Res 1997; 14: 325-8
17. Alyautdin RN, Gothier G, Petrov V, et al. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate80 coated poly(butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm 1995; 41: 44-8
18. Kreuter J, Alyautdin RN, Kharkevich DA, et al. Passage of peptides through the blood-brain barrier with colloidal polymeric particles (nanoparticles). Brain Res 1995; 674: 171-4
19. Steiniger SC, Kreuter J, Khalansky AS, et al. Chemotherapy of glioblastoma in rats using doxorubicin loaded nanoparticles. Int J Cancer 2004; 109: 759-67
20. Banerjee T, Mitra S, Singh AK, et al. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 2002 Aug 28; 243 (1-2): 93-105
21. Gaur U, Sahoo SK, De TK, et al. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 2000; 202: 1-10
22. Chauhan UP, Chander J, Mishra P, et al. 99mTc(Cu)-mannitol complex: a new agent for dynamic renal function studies. Int J Rad Appl Instrum B 1989; 16 (3): 283-9
23. Petrig J, Schibli R, Dumas C, et al. Derivatization of glucose and 2-deoxyglucose for transition metal complexation: substitution reactions with organometallic 99mTc and Re precursors and fundamental NMR investigations. Chemistry 2001 May 4; 7 (9): 1868-73
24. Dass R, Singh AK, Chauhan UPS. Development of dextran kit for labeling with 99mTc and its evaluation for lymphoscintigraphy. Nucl Med Biol 1993; 20: 701-6
25. Bhatnagar AK, Sharma R, Gupta S, et al. Possible role of 99mTc-Dextran in detection of occult small intestinal inflammation. Clin Nucl Med 1999; 24 (6): 424-7
26. Gulyaev AE, Gelperina SE, Skidan IN, et al. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 1999; 16 (10): 1564-9
27. Nerukar MM, Burto PS, Borchardt RT. The use of surfactants to enhance the permeability of peptides through Caco2 cells by inhibition of an apically polarized efflux system. Pharm Res 1996; 13: 528-34
28. Pardridge WM. Peptide drug delivery to the Brain. New York: Raven Press, 1991: 52-3
29. Wookcock DM, Linsenmeyer ME, Chojnowski G, et al. Reversal of multi drug resistance by surfactants. Br J Cancer 1992; 66 (1): 62-8